ÖÐÎÄÃû³Æ£º Íÿ¹PTK2 (Phospho-Tyr861) ¶à¿Ë¡¿¹Ìå
Ó¢ÎÄÃû³Æ£º Anti-PTK2 (Phospho-Tyr861) rabbit polyclonal antibody
±ð Ãû£º FAK; FADK; FAK1; FRNK; PPP1R71; p125FAK; pp125FAK
Ïà¹ØÀà±ð£º Ò»¿¹
´¢ ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â
ËÞ Ö÷£º Rabbit
¿¹ Ô£º PTK2 (Phospho-Tyr861)
·´Ó¦ÖÖÊô£º Human
±ê ¼Ç Î Unconjugate
¿Ë¡ÀàÐÍ£º rabbit polyclonal
¼¼Êõ¹æ¸ñ
|
Background: |
Non-receptor protein-tyrosine kinase implicated in signaling pathways involved in cell motility, proliferation and apoptosis. Activated by tyrosine-phosphorylation in response to either integrin clustering induced by cell adhesion or antibody cross-linking, or via G-protein coupled receptor (GPCR) occupancy by ligands such as bombesin or lysophosphatidic acid, or via LDL receptor occupancy. Plays a potential role in oncogenic transformations resulting in increased kinase activity. |
|
Applications: |
WB |
|
Name of antibody: |
PTK2 (Phospho-Tyr861) |
|
Immunogen: |
Synthetic peptide of human PTK2 (Phospho-Tyr861) |
|
Full name: |
protein tyrosine kinase 2 (Phospho-Tyr861) |
|
Synonyms£º |
FAK; FADK; FAK1; FRNK; PPP1R71; p125FAK; pp125FAK |
|
SwissProt: |
Q05397 |
|
WB Predicted band size: |
125 kDa |
|
WB Positive control: |
HT29 cells treated with EGF |
|
WB Recommended dilution: |
500-1000 |

¹ºÎï³µ
°ïÖú
021-54845833/15800441009
